North America Radiopharmaceuticals Market

North America Radiopharmaceuticals Market size was valued at USD 3.7 billion in 2025 and is forecast to grow from USD 4.0 billion in 2026 to reach USD 6.2 billion by 2031, at a CAGR of 10.8%.

Description

The North America Radiopharmaceuticals Market size was valued at USD 3.7 billion in 2025 and is forecast to grow from USD 4.0 billion in 2026 to reach USD 6.2 billion by 2031, at a CAGR of 10.8%. Radiopharmaceuticals are medicinal compounds containing radioactive isotopes used in nuclear medicine for both diagnostic imaging and targeted therapeutic applications, enabling precise disease localization through PET and SPECT imaging as well as targeted radiation delivery to diseased tissue with minimal impact on healthy cells. The market sits at the intersection of nuclear medicine, oncology, and precision-diagnostics manufacturing, making it one of the most closely watched enabling technologies across the regional healthcare and life-sciences value chain.

Demand for radiopharmaceutical products remains anchored by the rising incidence of cancer and cardiovascular disease, expanding theranostics adoption, and growing investment in isotope production infrastructure across the United States, Canada, and Mexico. Beyond oncology, radiopharmaceuticals continue to enable applications in cardiology, neurology, and targeted alpha and beta therapy that require precise, patient-specific radioactive dosing. Rising healthcare expenditure, expanding hospital nuclear medicine departments, and continued regulatory support for novel radioisotope approvals are sustaining consumption even as the region transitions toward more personalized, theranostics-driven treatment models.

Table of Contents

  • Product Overview

    1. Market Definition

    2. Scope of the Market

      1. Markets Covered

      2. Years Considered for Study

      3. Key Market Segmentations

  • Research Methodology

    1. Objective of the Study

    2. Baseline Methodology

    3. Key Industry Partners

    4. Major Association and Secondary Sources

    5. Forecasting Methodology

    6. Data Triangulation & Validation

    7. Assumptions and Limitations

  • Executive Summary

    1. Overview of the Market

    2. Overview of Key Market Segmentations

    3. Overview of Key Market Players

    4. Overview of Key Regions/Countries

    5. Overview of Market Drivers, Challenges, Trends

  • Voice of Customer

  • North America Radiopharmaceuticals Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product (Diagnostic Radiopharmaceuticals, Therapeutic Radiopharmaceuticals)

      2. By Application (Oncology, Cardiology, Neurology, Others)

      3. By End User (Hospitals & Clinics, Diagnostic Imaging Centers, Academic & Research Institutes, Others)

      4. By Country

      5. By Company (2025)

    3. Product Map

  • United States Radiopharmaceuticals Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Canada Radiopharmaceuticals Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Mexico Radiopharmaceuticals Market Outlook

    1. Market Size & Forecast

      1. By Value

    2. Market Share & Forecast

      1. By Product

      2. By Application

      3. By End User

  • Market Dynamics

    1. Drivers

    2. Challenges

  • Market Trends & Developments

    1. Merger & Acquisition (If Any)

    2. Product Launches (If Any)

    3. Recent Developments

  • North America Radiopharmaceuticals Market: SWOT Analysis

  • Porter's Five Forces Analysis

    1. Competition in the Industry

    2. Potential of New Entrants

    3. Power of Suppliers

    4. Power of Customers

    5. Threat of Substitute Products

  • Competitive Landscape

    1. Cardinal Health, Inc.

      1. Business Overview

      2. Products & Services

      3. Recent Developments

      4. Key Personnel

      5. SWOT Analysis

    2. GE HealthCare Technologies Inc.

    3. Lantheus Holdings, Inc.

    4. Curium Pharma

    5. Novartis AG

    6. Bayer AG

    7. Jubilant DraxImage Inc.

    8. NorthStar Medical Radioisotopes, LLC

    9. PharmaLogic Holdings Corp.

    10. Eckert & Ziegler AG

  • Strategic Recommendations

  • About Us & Disclaimer

    • Methodology